statistiche ricercatore

Nome	#
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity	66
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration	51
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.	44
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.	41
HMGA1 protein is a novel target of the ATM kinase.	32
The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization.	32
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.	31
Analysis of UbcH10 expression represents a useful tool for the diagnosis and therapy of astrocytic tumors.	26
Pit-1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.	26
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents.	25
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis.	22
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy	22
Hmga1 null mice are less susceptible to chemically induced skin carcinogenesis.	20
Regulation of microRNA expression by HMGA1 proteins.	18
Totale	456

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	31	15	0	3	0	3	0	0	0	0	1	1	8
2020/2021	40	2	2	6	3	3	6	3	1	4	1	3	6
2021/2022	71	1	0	0	0	0	3	0	2	11	12	13	29
2022/2023	183	16	22	9	19	28	19	0	18	31	12	6	3
2023/2024	54	4	13	4	9	6	11	1	5	1	0	0	0
Totale													456